Cargando…

Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery

Background and Objective: Most patients with prolactinomas receive pharmacological treatment only, resulting in limited research on the predictors of successful prolactinoma surgery. In this study, we analyzed whether early postoperative serum prolactin concentrations and selected tumor characterist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zielinski, Grzegorz, Ozdarski, Marcin, Maksymowicz, Maria, Szamotulska, Katarzyna, Witek, Przemysław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358351/ https://www.ncbi.nlm.nih.gov/pubmed/32733387 http://dx.doi.org/10.3389/fendo.2020.00439

Ejemplares similares

Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery”
por: Andereggen, Lukas, et al.
Publicado: (2021)

Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre
por: Witek, Przemysław, et al.
Publicado: (2016)

Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing’s Disease
por: Rak, Beata, et al.
Publicado: (2021)

Transsphenoidal surgery for prolactinomas in male patients: a retrospective study
por: Su, Wei-Jie, et al.
Publicado: (2022)

Cushing's Disease: The Relevance of a Combined Dexamethasone Desmopressin Test as a Component of Postoperative Hormonal Evaluation
por: Witek, Przemysław, et al.
Publicado: (2015)

The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings
por: Witek, Przemysław, et al.
Publicado: (2021)

Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery
por: Han, Yan-Long, et al.
Publicado: (2018)

Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists
por: Park, Kawngwoo, et al.
Publicado: (2021)

Postoperative water and electrolyte disturbances after extended endoscopic endonasal transsphenoidal surgery
por: Canelo Moreno, Juan Manuel, et al.
Publicado: (2022)

Novel Nomograms to Predict Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma
por: Lin, Kunzhe, et al.
Publicado: (2022)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas
por: Huber, Markus, et al.
Publicado: (2022)

Increased Thoracic Fluid as the Most Distinctive Cardiovascular Hemodynamic Alteration in Men with Prolactinoma
por: Jurek, Agnieszka, et al.
Publicado: (2022)

Clival ectopic pituitary prolactinoma was successfully managed by transsphenoidal surgery: A rare case report
por: Mansour, Marah, et al.
Publicado: (2023)

Managing Prolactinomas during Pregnancy
por: Almalki, Mussa Hussain, et al.
Publicado: (2015)

Cushing’s Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography
por: Jurek, Agnieszka, et al.
Publicado: (2021)

Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center
por: Liu, Jie, et al.
Publicado: (2022)

Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
por: Indirli, Rita, et al.
Publicado: (2021)

Ketoconazole as second-line treatment for Cushing’s disease after transsphenoidal surgery: systematic review and meta-analysis
por: Viecceli, Camila, et al.
Publicado: (2023)

Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study
por: Coopmans, Eva C, et al.
Publicado: (2021)

A retrospective analysis of postoperative hypokalemia in pituitary adenomas after transsphenoidal surgery
por: You, Lili, et al.
Publicado: (2017)

Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
por: Uziȩbło-Życzkowska, Beata, et al.
Publicado: (2020)

Outcome of Endoscopy-Assisted Microscopic Extended Transsphenoidal Surgery for Suprasellar Adult Craniopharyngiomas
por: Ikeda, Hidetoshi, et al.
Publicado: (2012)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022)

Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
por: Bima, Chiara, et al.
Publicado: (2021)

Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center
por: Chen, Yike, et al.
Publicado: (2022)

Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?
por: Vilar, Lucio, et al.
Publicado: (2015)

Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
por: Cho, Anna, et al.
Publicado: (2022)

Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?
por: Ferraris, Jimena
Publicado: (2023)

FRI299 Efficacy And Safety Of Endoscopic Transsphenoidal Resection For Prolactinoma: A Retrospective Case-series
por: Zandbergen, Ingrid M, et al.
Publicado: (2023)

Acromegaly: The Research and Practical Value of Noninvasive Hemodynamic Assessments via Impedance Cardiography
por: Jurek, Agnieszka, et al.
Publicado: (2022)

The patient’s sex determines the hemodynamic profile in patients with Cushing disease
por: Jurek, Agnieszka, et al.
Publicado: (2023)

Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery
por: Pérez-Pevida, Belén, et al.
Publicado: (2019)

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists
por: Tang, Hao, et al.
Publicado: (2021)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022)

Prolactinoma: Clinical Characteristics, Management and Outcome
por: Irfan, Hira, et al.
Publicado: (2022)

Outcome of Endoscopic Transsphenoidal Surgery for Recurrent or Residual Pituitary Adenomas and Comparison to Non-Recurrent or Residual Cohort by Propensity Score Analysis
por: Gong, Xuan, et al.
Publicado: (2022)

Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
por: Gonzaga, Maria de Fátima de Magalhães, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6plj56224mtjrj68mhefsslqm4